Anti-IgE monoclonal antibody medication for treating asthma and allergy. Brand name Xolair.
Sites 7
- Xolair Information about allergic asthma, how the medication works, and sections for patients, family and friends, and medical professionals.
- PubMed Central: Omalizumab: A Monoclonal Anti-IgE Antibody Descriptions of allergic asthma and allergic rhinitis pathophysiology and reviews of the pharmacologic, pharmacokinetic, pharmacodynamic, efficacy, and safety data for omalizumab.
- JACI: Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma Description and analysis of cases of anaphylaxis following omalizumab administration, published in The Journal of Allergy and Clinical Immunology.
- Xolair Pregnancy Registry Information for patients and health care providers about an observational study of pregnant women in the US taking Xolair.
- The Johns Hopkins Gazette: Why We Sneeze and Sneeze Article about clinical testing of the experimental anti-allergy agent Anti-IgE, in a version called rhuMAb-E25.
- Genentech: Xolair Includes fact sheet, prescribing information, and how it's manufactured.
- MedlinePlus: Omalizumab Injection Features information about dosage, usage, warnings, and side effects.